Clinical Trial Update: L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating L-citrulline to prevent sequelae of acute lung injury in children having cardiopulmonary bypass for congenital heart defects has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury

Drugs mentioned

• L-citrulline (L-citrulline)

Snippet

Sponsor: Asklepion Pharmaceuticals, LLC | Conditions: Acute Lung Injury | Phase 3 | Status: COMPLETED | Results posted: 2023-02-23